Pezzilli Raffaele, Morselli Labate Antonio M, Fantini Lorenzo, Gullo Lucio, Corinaldesi Roberto
Department of Internal Medicine, Sant'Orsola-Malpighi Hospital, University di Bologna, Bologna, Italy.
Pancreas. 2007 Mar;34(2):191-6. doi: 10.1097/mpa.0b013e31802e0301.
There are no data available that evaluate the possible modifications of the quality of life during the clinical course of chronic pancreatitis. To evaluate the outcome for patients with chronic pancreatitis in a 2-year follow-up study.
The Short Form 12 Health Survey Italian version questionnaire was used for the purpose of the study. The questionnaire generates 2 summary scores: the physical component summary (PCS-12) and the mental component summary (MCS-12). Eighty-three patients with chronic pancreatitis were studied with a mean (+/-SD) interval time of 2.3 +/- 0.2 years between the first and the second evaluation.
There was a significant increase in the frequency of diabetes mellitus (P = 0.008), nonpancreatic surgery (P = 0.016), and comorbidities (P = 0.004). The PCS-12 (44.7 +/- 10.7) and MCS-12 (44.1 +/- 13.3) were not significantly different in comparison with the baseline evaluation (PCS-12, 43.7 +/- 9.8; MCS-12, 44.3 +/- 11.4). The PCS-12 score worsened in 17 (20.5%) patients, 44 (53.0%) had a stable PCS-12 score, and the remaining 22 (26.5%) improved their PCS-12 score. Regarding the mental score, 15 (18.1%) patients worsened, 52 (62.7%) had a stable MCS-12 score, and the remaining 16 (19.3%) improved their MCS-12 score. Only age at diagnosis was significantly related to the change of the MCS-12 score (P = 0.028, positive relationship).
The information given by quality-of-life assessment should be routinely included in the work-up of patients affected by chronic pancreatitis to select those patients with severely impaired physical and mental scores, and to plan an intensive program of medical and psychological follow-up.
尚无数据评估慢性胰腺炎临床病程中生活质量的可能变化。在一项为期2年的随访研究中评估慢性胰腺炎患者的预后。
本研究使用简短健康调查问卷意大利语版。该问卷产生2个总结分数:身体成分总结(PCS-12)和心理成分总结(MCS-12)。对83例慢性胰腺炎患者进行了研究,首次评估与第二次评估之间的平均(±标准差)间隔时间为2.3±0.2年。
糖尿病(P = 0.008)、非胰腺手术(P = 0.016)和合并症(P = 0.004)的发生率显著增加。与基线评估相比,PCS-12(44.7±10.7)和MCS-12(44.1±13.3)无显著差异(PCS-12,43.7±9.8;MCS-12,44.3±11.4)。17例(20.5%)患者的PCS-12评分恶化,44例(53.0%)患者的PCS-12评分稳定,其余22例(26.5%)患者的PCS-12评分改善。关于心理评分,15例(18.1%)患者恶化,52例(62.7%)患者的MCS-12评分稳定,其余16例(19.3%)患者的MCS-12评分改善。仅诊断时的年龄与MCS-12评分的变化显著相关(P = 0.028,正相关)。
生活质量评估所提供的信息应常规纳入慢性胰腺炎患者的检查中,以筛选出身体和心理评分严重受损的患者,并规划强化的医学和心理随访方案。